C
Cytokinetics, Incorporated
Q3 2026 earnings expected
Quarter
Jul – Sep
Expected
November 4, 2026(ET)
Revenue Growth Trajectory
-57%YoY
Last 7 quarters
Analyst consensus · $58M · 13 analysts
As of 8/30, 18:00 KST
Cytokinetics, Incorporated
Jul – Sep
November 4, 2026(ET)
Last 7 quarters
Analyst consensus · $58M · 13 analysts
As of 8/30, 18:00 KST